Company Filing History:
Years Active: 2020-2025
Title: Byungchan Kim: Innovator in Integrin Research
Introduction
Byungchan Kim is a notable inventor based in West New York, NJ (US). He has made significant contributions to the field of integrin research, holding a total of seven patents. His work focuses on developing small molecule antagonists and inhibitors that target specific integrins, which are crucial in various diseases.
Latest Patents
Among his latest patents, Byungchan Kim has disclosed small molecule antagonists of human integrin α4β7. These antagonists are designed to treat a number of specific diseases or conditions. Additionally, he has developed small molecule inhibitors of αvβ6 integrin, which also aim to address various diseases and conditions.
Career Highlights
Throughout his career, Byungchan Kim has worked with prominent companies in the biotechnology sector, including Morphic Therapeutics, Inc. and Schrödinger, Inc. His innovative research has positioned him as a key figure in the development of therapeutic solutions targeting integrins.
Collaborations
Byungchan Kim has collaborated with several professionals in his field, including Matthew Gregory Bursavich and Dawn M Troast. These collaborations have further enhanced his research and contributions to integrin-related therapies.
Conclusion
Byungchan Kim's work in integrin research exemplifies the impact of innovative thinking in the medical field. His patents and collaborations highlight his commitment to advancing therapeutic options for various diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.